Results for “ ”

Entry Author Date Location
Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer 10/02/18 San Francisco
Madison Startup Asto CT Raises $1.1M for Large Animal Imaging Device 10/01/18 Wisconsin
FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize 10/01/18 National
10 San Diego Startups to Compete at Region’s Top Pitch Competition 10/01/18 San Diego
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison, Honjo 10/01/18 National
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic 10/01/18 San Diego
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines 09/28/18 Indiana
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
With CRISPR’s Help, KSQ Touts 13 Cancer Drugs and Bags Another $80M 09/28/18 Boston
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
With a New Name, Afyx Aims to Improve Oral Disease Treatment 09/27/18 San Diego
Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk 09/27/18 Indiana
Geron’s Drug Alliance with Janssen Terminated, Shares Plummet 68% 09/27/18 San Francisco
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug 09/27/18 Boston
Akrevia Launches with $30M for Next-Gen Cancer Immunotherapy 09/27/18 Boston
Big Pharma Seeks More Partnerships, Evidence in Digital Therapeutics 09/26/18 Boston
LogicBio Jumps on the Gene Therapy 2.0 Wave and Lines Up an IPO 09/26/18 Boston
Syntimmune Turns Drug For Rare Anemia Into $400M Alexion Buyout 09/26/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
VelocityTX Taps 8 South America Startups for San Antonio Accelerator 09/25/18 Texas
Two Gemphire Execs Caught in Layoffs After Clinical Trial Setbacks 09/25/18 Detroit Ann Arbor
Morphic Nets Another $80M For Integrin Drugs & First Human Tests 09/25/18 Boston
Alexion Hits Study Goals, Could Expand Blockbuster Drug to CNS 09/24/18 Boston
Gilead to Make Generic Hepatitis C Drugs and Cut Prices Up to 75% 09/24/18 San Francisco
Another Precision Step for Roche as Ignyta Drug Heads to Regulators 09/24/18 San Francisco
Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study 09/24/18 New York
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug 09/21/18 San Diego
Y-mAbs Upsizes IPO, Gets $96M to Test Two Pediatric Cancer Drugs 09/21/18 New York
Europe Advisory Panel Rejects Sarepta’s Duchenne Drug Once Again 09/21/18 Boston
Microbiome Startup uBiome Expands into Drug Research with $83M 09/21/18 San Francisco
Page 2 of 356 « previous page · next page »